122 related articles for article (PubMed ID: 31352852)
1. Does a history of malignancy impact the survival of a subsequent endometrial adenocarcinoma? Should clinical trials eligibility criteria be revisited?
Mohamed HH; Ibrahim Sokkar M; Afifi AM; Saad AM; Albarouki S; Al-Husseini MJ
J Obstet Gynaecol; 2020 Feb; 40(2):233-239. PubMed ID: 31352852
[TBL] [Abstract][Full Text] [Related]
2. Impact of Prior Malignancy on Survival Outcomes of Stage IV Pancreatic Adenocarcinoma: SEER-Based Cohort.
Al-Husseini MJ; Saad AM; Turk T; Tabash MA; Abdel-Rahman O
J Gastrointest Cancer; 2019 Dec; 50(4):794-800. PubMed ID: 30105523
[TBL] [Abstract][Full Text] [Related]
3. Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study.
Saad AM; Al-Husseini MJ; Elgebaly A; Aboshady OA; Salahia S; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2018 Apr; 12(4):417-423. PubMed ID: 29316808
[TBL] [Abstract][Full Text] [Related]
4. Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria.
Al-Husseini MJ; Saad AM; Mohamed HH; Alkhayat MA; Sonbol MB; Abdel-Rahman O
BMC Cancer; 2019 Aug; 19(1):863. PubMed ID: 31470823
[TBL] [Abstract][Full Text] [Related]
5. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
[No Abstract] [Full Text] [Related]
6. Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study.
Al-Husseini MJ; Saad AM; El-Shewy KM; Nissan NE; Gad MM; Alzuabi MA; Samir Alfaar A
Int J Neurosci; 2019 May; 129(5):447-454. PubMed ID: 30366515
[TBL] [Abstract][Full Text] [Related]
7. Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.
Lajer H; Elnegaard S; Christensen RD; Ortoft G; Schledermann DE; Mogensen O
Acta Obstet Gynecol Scand; 2012 Aug; 91(8):976-82. PubMed ID: 22548255
[TBL] [Abstract][Full Text] [Related]
8. Impact of prior cancer history on survival of patients with gastric cancer.
Wen L; Yu K; Lu H; Zhong G
Eur J Surg Oncol; 2021 Sep; 47(9):2286-2294. PubMed ID: 33632589
[TBL] [Abstract][Full Text] [Related]
9. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma.
Lee CM; Szabo A; Shrieve DC; Macdonald OK; Gaffney DK
JAMA; 2006 Jan; 295(4):389-97. PubMed ID: 16434629
[TBL] [Abstract][Full Text] [Related]
10. The role of adjuvant radiation in lymph node positive endometrial adenocarcinoma.
Shaikh T; Churilla TM; Mantia-Smaldone GM; Chu C; Rubin SC; Anderson PR
Gynecol Oncol; 2016 Jun; 141(3):434-439. PubMed ID: 27090796
[TBL] [Abstract][Full Text] [Related]
11. Stage I and II Endometrial Adenocarcinoma: Analysis of 2009 FIGO Staging Revision and Impact on Survival by Adjuvant Therapy.
Cahan B; Kim JH; Schultheiss TE; Wong JYC; Chen YJ
Am J Clin Oncol; 2018 Mar; 41(3):302-306. PubMed ID: 26886945
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of Hepatocellular Carcinoma Among Cancer Survivors with Other Types of Primary Tumors.
Bian X; He X; Yang L; Wu W; Li L
Dig Dis Sci; 2020 Jul; 65(7):2140-2147. PubMed ID: 31673904
[TBL] [Abstract][Full Text] [Related]
13. Lack of improvement in survival rates for women under 50 with endometrial cancer, 2000-2011.
Rodriguez AM; Schmeler KM; Kuo YF
J Cancer Res Clin Oncol; 2016 Apr; 142(4):783-93. PubMed ID: 26670165
[TBL] [Abstract][Full Text] [Related]
14. Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis.
Rauh-Hain JA; Vargas RJ; Clemmer J; Clark RM; Bradford LS; Growdon WB; Goodman A; Boruta DM; Schorge JO; del Carmen MG
Am J Clin Oncol; 2016 Feb; 39(1):43-8. PubMed ID: 24390270
[TBL] [Abstract][Full Text] [Related]
15. Endometrial carcinoma and diabetes revisited.
Papanas N; Giatromanolaki A; Galazios G; Maltezos E; Sivridis E
Eur J Gynaecol Oncol; 2006; 27(5):505-8. PubMed ID: 17139988
[TBL] [Abstract][Full Text] [Related]
16. Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual.
Laccetti AL; Pruitt SL; Xuan L; Halm EA; Gerber DE
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25667420
[TBL] [Abstract][Full Text] [Related]
17. Is the 2009 FIGO staging system really valuable for stage I endometrial cancer?
Atalay F; Cetinkaya K; Bacinoglu A
Eur J Gynaecol Oncol; 2013; 34(6):556-8. PubMed ID: 24601051
[TBL] [Abstract][Full Text] [Related]
18. Brachytherapy Is Associated With Improved Survival in Inoperable Stage I Endometrial Adenocarcinoma: A Population-Based Analysis.
Acharya S; Perkins SM; DeWees T; Fischer-Valuck BW; Mutch DG; Powell MA; Schwarz JK; Grigsby PW
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):649-57. PubMed ID: 26461007
[TBL] [Abstract][Full Text] [Related]
19. Temporal pattern of recurrence of stage I endometrial cancer in relation to histological risk factors.
Ben Arie A; Lavie O; Gdalevich M; Voldarsky M; Barak F; Schneider D; Levy T; Anteby E; Gemer O
Eur J Surg Oncol; 2012 Feb; 38(2):166-9. PubMed ID: 22056646
[TBL] [Abstract][Full Text] [Related]
20. Endometrial adenocarcinoma: clinicopathologic and survival characteristics in Yazd, Iran.
Binesh F; Akhavan A; Behniafard N; Jalilian S
Asian Pac J Cancer Prev; 2014; 15(6):2797-801. PubMed ID: 24761903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
